PR Newswire Clinical TrialsOriginal article
START Strengthens Dallas-Fort Worth Leadership with Dr. Salwan Al Mutar as Director of Clinical Research
Positive
AI Analysis
Summary
START Center for Cancer Research appoints Dr. Salwan Al Mutar as Director of Clinical Research in Dallas-Fort Worth to expand access to innovative therapies. The appointment leverages his expertise in gastrointestinal oncology and early-phase clinical trials.
Importance:2/10
Sentiment:
0.30
LeadershipClinical ResearchGastrointestinal OncologyEarly-phase trialsTexas
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on April 9, 2026 12:01 PM